Publications
- MxA mRNA decrease preceding NAb detection in IFN beta-treated MS patients2017 | First Faculty of Medicine, Second Faculty of Medicine
- Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFN beta2017 | First Faculty of Medicine, Second Faculty of Medicine
- Myxovirus resistance protein A in interferon-β therapy in patients with multiple sclerosis and treatment effectiveness monitoring algorithm2016 | First Faculty of Medicine, Second Faculty of Medicine
- Neutralising antibodies and Myxovirus resistance protein A as a marker of biological response to interferon β2014 | Second Faculty of Medicine
- Interferon-β biological activity; monitoring of the treatment effect in multiple sclerosis patients in the Czcech republic2013 | Second Faculty of Medicine
- Monitoring of the Biological Effect of Interferon Beta in the Treatment of Multiple Sclerosis2013 | Second Faculty of Medicine
- Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study2012 | Second Faculty of Medicine
- Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple Sclerosis2012 | Second Faculty of Medicine
- Correlation of MchA mRNA expression with NAbs levels in patients with multiple sclerosis2011 | Second Faculty of Medicine
- Supportive strategies to improve adherence to IFN beta-1b in Multiple Sclerosis - Results of the BetaPlus observational cohort study2011 | Second Faculty of Medicine
Loading network view...